In the AMPP study, as shown on the slide, the prevalence of a variety of comorbid conditions increased as the number of monthly headache days (MHDs) increased.[Buse et al., 2020]

Reference:
Buse DC, Reed ML, Fanning KM, et al. Demographics, headache features, and comorbidity profiles in relation to headache frequency in people with migraine: results of the American Migraine Prevalence and Prevention (AMPP) study. Headache 2020; 60 (10): 2340–2356.